Development and Validation of a Quantitative Polymerase Chain Reaction Assay to Evaluate Minimal Residual Disease for T-Cell Acute Lymphoblastic Leukemia and Follicular Lymphoma

American Journal of Pathology - United States
doi 10.1016/s0002-9440(10)65355-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search